Daniella Kranjac

Curi Bio, Inc. is engaged in providing drug development services. The company was founded by Elliot Fisher and Deol-Ho Kim and is headquartered in Seattle, WA.

Curi Bio, Inc. is engaged in providing drug development services. The company was founded by Elliot Fisher and Deol-Ho Kim and is headquartered in Seattle, WA.

Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018.

Alpenglow Biosciences, Inc. engages in the development and production of three-dimensional open-top light-sheet microscope for the improvement of conducting pathology. The company was founded by Steven Buckley, Adam Glaser, Jonathan Liu, Nicholas Reder, and Larry True in 2018 and is headquartered in Seattle, WA.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

Curi Bio, Inc. is engaged in providing drug development services. The company was founded by Elliot Fisher and Deol-Ho Kim and is headquartered in Seattle, WA.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018.

RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD.

Curi Bio, Inc. is engaged in providing drug development services. The company was founded by Elliot Fisher and Deol-Ho Kim and is headquartered in Seattle, WA.

Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

Vernal Biosciences, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that specializes in manufacturing and formulating mRNA and LNP-mRNA. Vernal's focus is on democratizing access to their expertise and unparalleled LNP-platform technologies to accelerate the potential of mRNA. The American company provides comprehensive high purity platform manufacturing solutions for mRNA-based medicines, from research to clinical development. Vernal Biosciences is pioneering the custom development and manufacturing process for a variety of applications including vaccine development, gene replacement, and more. The company was founded in 2021 and is headquartered just outside of an undisclosed location. The company was founded by Cobaugh Christian, who has been the CEO since incorporation.

Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

Vernal Biosciences, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that specializes in manufacturing and formulating mRNA and LNP-mRNA. Vernal's focus is on democratizing access to their expertise and unparalleled LNP-platform technologies to accelerate the potential of mRNA. The American company provides comprehensive high purity platform manufacturing solutions for mRNA-based medicines, from research to clinical development. Vernal Biosciences is pioneering the custom development and manufacturing process for a variety of applications including vaccine development, gene replacement, and more. The company was founded in 2021 and is headquartered just outside of an undisclosed location. The company was founded by Cobaugh Christian, who has been the CEO since incorporation.

CellFE, Inc. develops delivery platform to enable engineering of life-saving therapies. The company was founded by Anna Liu and Alla Zamarayeva in 2018 and is headquartered in San Carlos, CA.

RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD.

Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018.